Doctors Lounge -- A baseline panel of oxidative biomarkers and lipoprotein(a) in healthy subjects can be combined with traditional risk factors to better estimate coronary artery disease risk, according to a study in the Sept. 14 issue of the Journal of the American College of Cardiology.
